1. INTRODUCTION

Twinning is a complex event occurring in approximately 1 in 80 spontaneous pregnancies, with an increased incidence of 1 in 4 for babies conceived by in vitro fertilisation (IVF) (1, 2). Variation exists across twinning events and can be differentiated by zygosity (1, 3–6). This term refers to whether twins originate from one fertilised egg, defined as monozygotic, from two eggs fertilised by two different sperm, dizygotic, or a postulated intermediate of these events defined as sesquizygotic (Fig. 1) (1, 3–6). An understanding of twinning events requires knowledge across relevant fields of obstetrics, developmental biology, and clinical and molecular genetics (1).

In the present text, the characteristics and main causes of monozygotic and dizygotic twinning will be examined, and their increased incidence in IVF will be discussed.

Twinning DNA schema

Figure 1: Various twinning events (7)

2. MONOZYGOTIC TWINS

Monozygotic twins, more commonly known as identical twins, originate from one fertilised egg, producing a single zygote which divides and develops into two independent and genetically identical embryos (8). Although embryos are expected to be genetically identical, monozygotic twins show a high degree of discordance for complex genetic traits and disorders (1, 4). This genetic discordance is attributable to somatic mutations in cells, arising due to differential epigenetic control and stochastic processes over the course of development (4).

Monozygotic twin pairs represent approximately a third of all spontaneous twins, and while this rate remains stable across populations, ethnicity and race, the specific cause of monozygosity in humans has not yet been established (9). However, evidence suggests that monozygotic twinning may be associated with a suboptimal zona pellucida, inner cell mass or the age of the oocyte after ovulation (1, 2). Furthermore, skewed X chromosome inactivation may provide an alternative explanation for the increased incidence of monozygotic twins in humans (10–12).

The inactivation of one X-chromosome during early mammalian female development occurs in order to maintain the correct expression of genes (13). In rare cases, X-linked mutations may influence cell viability, resulting in a preference for the activation of the other X chromosome (12). This event is thought to occur when the initial zygote contains three chromosome sets and loses one to form a diploid zygote (12). The reduction in progenitor pool size results in extreme X-chromosome skewing (10). A similar mechanism is thought to explain the increased incidence of monozygotic twinning in humans, although this concept still remains controversial (10).

As briefly noted, evidence in animals has indicated that damage to the inner cell mass or zona pellucida may also be associated with monozygotic twinning (14). When considering the cyclic nature of human reproduction, the fertilisation of an ‘older’ oocyte with a more delicate zona pellucida could result in the blastocyst splitting in two (1, 14). The cytoplasm of an ‘older’ ovum may not have sufficient nutrient and energy sources, resulting in developmental delay and an increased risk of programming errors (1, 15). Additionally, familial monozygotic twinning may be an inherited defect involving zona pellucida proteins, causing the zona to be more susceptible to the early separation of blastomeres, failure or delay of cell-to-cell recognition and adhesion (9).

Frequency and relevance to Assisted Reproduction Techniques (ARTs)

In 2011 there was approximately a 36% increase in the occurrence of monozygotic twins as a result of ART procedures in the United States (16). While a reduction in the proportion of higher order births followed changes in the regulations surrounding the transfer of three or more embryos during IVF (16), the rate of monozygotic twinning remains higher in ART compared to spontaneous conceptions (17). Specifically, monozygosity following ART has been established to be higher for day 5-6 transfers compared to day 2-3 transfers, whereas intracytoplasmic sperm injection (ICSI) seemed to reduce the incidence of monozygotic twins (18). Although these findings do not consider all potential risk factors influencing the incidence of monozygosity in ART, they assist in the greater understanding and prevention of such cases.

The increased prevalence of monozygotic twinning in both spontaneous pregnancies and in IVF is thought to be associated with a suboptimal or even absent zona pellucida (1, 19, 20). The zona may be damaged as a result of handling or penetration during ICSI (1). In addition, increased age, follicle-stimulating drugs or culture media could induce zona hardening (19). If zona pellucida is absent, damaged or hardens during the early zygote stages when tight junctions between cells have not yet been established, blastomeres could fall apart, thus resulting in regrowth from two points (19, 20). This hypothesis is supported by the fact that dichorionic diamniotic twins occur more frequently than expected in IVF. It also suggests that monozygotic twinning process and subsequent separation of twins observed in IVF happen at an early stage (19, 20).

3. DIZYGOTIC TWINS

Dizygotic twins arise from two separate oocytes ovulated at the same time, followed by independent events of fertilisation by a single spermatozoon (1, 3). Although not common in humans, the ovulation of multiple dominant follicles during the same menstrual cycle may occur due to hypothalamic-pituitary-ovarian axis dysregulation (21–23). Thus, dizygotic twinning depends on a multiple ovulation event, the timing of intercourse and subsequent fertilisation of both oocytes (24).

If both ovulated oocytes are fertilised by spermatozoa from one male, dizygotic twins are expected to share 50% of their genes from each parent, like any other pair of siblings (1). However, there are several reported cases of dizygotic twins with different paternal genetic contributions, which may be explained by superfetation. In this circumstance, two separate fertilisation and implantation events occur in subsequent ovulation cycles; in these cases, a second zygote implants in the uterus, where pregnancy had already been achieved previously (25, 26).

Dizygotic twinning has been associated with higher concentrations of maternal follicle-stimulating hormone (FSH) (23, 27). As FSH levels change depending on age, geographical location, season, body mass index (BMI) and ethnic origin, the frequency of spontaneous dizygotic twinning varies widely among population groups (1). FSH levels increase with BMI and/or age, with the most significant increment at the age of 37. Additionally, due to the circadian regulation of FSH, levels fluctuate in response to variation of daylight and to seasonal and geographical effects (27, 28). A high frequency of dizygotic pregnancies has been observed in equatorial Africa and during the summer months in North Finland and Japan (15, 21).

Predisposition to dizygotic twinning pregnancies may be inherited through both autosomal recessive, autosomal dominant, and paternally derived inheritance patterns (29, 30). It has been reported that genes associated with dizygotic twinning are linked to chromosome 3 and are carried by 7–15% of the population (31). Inheritance of these genes may confer a presumptive selective advantage by producing more offspring; however, it is correspondingly associated with a high trade-off risk associated with multiple pregnancy (32).

Other theoretical mechanisms of dizygotic twinning exist, such as polar body twinning, where fertilisation of the oocyte and polar body occur by separate spermatozoa (1). However, this occurrence has been reported only once, and no viable offspring were produced (33).

Frequency and relevance to ARTs

Since 1980, accompanying the prevalence of ARTs involving ovulation stimulation drugs, there has been a dramatic rise in dizygotic twinning rate (15, 34). In the context of IVF, dizygotic twinning is more likely to take place when more than one embryo is transferred into the uterus (1, 35), given the chances of survival.

4. PLACENTATION IN TWINS

Placental development differs depending on zygosity, and its connection with perinatal mortality has been previously reported in a variety of studies (3, 5, 6). Timing of embryo division is thought to influence placental development in monozygotic twins. Whereas dizygotic twins exhibit dichorionic diamniotic placentation, defined as separate placentas and membranes, 1-2% of dizygotic twins exhibit one placenta and associated membranes, referred to as monochorionic monoamniotic placentation. In contrast, 70-75% of monozygotic twins share one placenta with monochorionic diamniotic membranes, while the remaining 25% presents with dichorionic diamniotic placentation (Fig. 2, 3) (1).

For these reasons, in 1973, clinicians Benirschke and Chung proposed the examination of placental membranes in order to determine zygosity, type of chorion and presence of anomalies in multiple pregnancies (3). Current practice outlined in the National Institute for Health and Care Excellence (NICE) guidelines for twin and triplet pregnancy involves antenatal screening and diagnostic monitoring for multiple pregnancies (36). For practical reasons and until proven otherwise, a monochorionic placenta is assessed as a monozygotic twin pregnancy. In the case of dichorionic placentas, if twins appear to seem similar at birth, biochemical studies such as blood types, enzyme polymorphisms and Human Leukocyte Antigens (HLA) are completed to determine monozygosity (1, 6).

Three types of monozygotic placenta and membranes
Figure 2. Three types of monozygotic placenta and membranes: a) Dichorionic diamniotic pregnancy; b) Monochorionic pregnancy; c) Monochorionic monoamniotic pregnancy (1)
Schematic drawing of normal human embryonic development with the timing of monozygotic twinning superimposed
Figure 3: Schematic drawing of normal human embryonic development with the timing of monozygotic twinning superimposed (1). In normal embryogenesis, the chorion begins to form around day 3, with the amnion forming between day 6 and 8 (1, 6). However, in monozygotic twins with dichorionic diamniotic placentation, separation is thought to take place between day 0 and day 3 (1, 6). In contrast, monozygotic twinning with monochorionic diamniotic placentation is thought to arise after the chorion has formed, approximately between day 4 and 7 (1, 6). This differs from monozygotic twins with monochorionic monoamniotic placentation, which are most likely to arise between day 7 and 14 (6).

Placentation and membrane type allow for the estimation of the timing of twinning events and the percentage of surviving twin pregnancies (Table 1) (6). Monochorionic monoamniotic placentation of all types accompanies a high risk of vascular compromise due to umbilical cord twisting (5). Such imbalance may result in twin reversed arterial perfusion sequence; this is a rare variation of twin-twin transfusion syndrome in which the blood systems of the twins are combined, causing severe malformation and disruptive congenital anomalies (1, 5). Additionally, the sharing of hematopoietic stem cells due to vascular connections may result in microchimerism between dizygotic twins and mosaicism, should genetic discordance arise between monozygotic twins (35).

type of monozygotic twins by days and surviving
Table 1. Subtypes of monozygotic twins according to placentation (1)

5. CONCLUSIONS

Twinning events provide insight into the cellular mechanisms occurring during embryogenesis. However, the long-held notion that twins are either monochorionic or dizygotic has been challenged by a recent rare case report indicating the existence of sesquizygosity, a third type of twinning (37). The mechanisms involved in sesquizygosity, its relevance to triploidy and implications in ART will be discussed in a future post.

Multiple pregnancies whether monozygotic, dizygotic or sesquizygotic are associated with various risks and complications for both the mother and foetuses, which in some cases may even result in stillbirth. A greater understanding of the aetiology and mechanisms involved in twinning events may aid management and possible prevention of such cases. As for ART, the goal of reducing the incidence of multiple pregnancies has been pushing forward the efforts to move definitively to the leading strategy of single embryo transfer.

Check part II: Sesquizygosity.

REFERENCES

  1. Hall JG. Twinning. Lancet. 2003;362(9385):735–43.
  2. Luo L, Fan X, Jie H, Gao Y, Chen M, Zhou C, et al. Is it worth reducing twins to singletons after IVF‐ET? A retrospective cohort study using propensity score matching. Acta Obstet Gynecol Scand. 2019;
  3. Benirschke K, Kim CK. Multiple pregnancy. N Engl J Med. 1973;288(24):1276–84.
  4. Kaminsky ZA, Tang T, Wang S-C, Ptak C, Oh GHT, Wong AHC, et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet. 2009;41(2):240.
  5. Feng B, Zhai J, Cai Y. Effect of twin pregnancy chorionic properties on maternal and fetal outcomes. Taiwan J Obstet Gynecol. 2018;57(3):351–4.
  6. Fitzgerald B. Histopathological examination of the placenta in twin pregnancies. Apmis. 2018;126(7):626–37.
  7. The University of New South Wales Newsroom (UNSW). Semi-identical twins identified in pregnancy for the first time [Internet]. UNSW, NSW, Australia; 2019 [cited 2019 Jun 9]. Available from: https://newsroom.unsw.edu.au/news/health/semi-identical-twins-identified-pregnancy-first-time.
  8. Vela G, Luna M, Barritt J, Sandler B, Copperman AB. Monozygotic pregnancies conceived by in vitro fertilization: understanding their prognosis. Fertil Steril. 2011;95(2):606–10.
  9. Harvey MAS, Huntley RMC, Smith DW. Familial monozygotic twinning. J Pediatr. 1977;90(2):246–8.
  10. Gribnau J, Barakat TS. X-chromosome inactivation and its implications for human disease. bioRxiv. 2017;76950.
  11. Lau AW, Brown CJ, Penaherrera M, Langlois S, Kalousek DK, Robinson WP. Skewed X-chromosome inactivation is common in fetuses or newborns associated with confined placental mosaicism. Am J Hum Genet. 1997;61(6):1353–61.
  12. Kristiansen M, Knudsen GPS, Bathum L, Naumova AK, Sørensen TIA, Brix TH, et al. Twin study of genetic and aging effects on X chromosome inactivation. Eur J Hum Genet. 2005;13(5):599.
  13. Helene Ørstavik K. Skewed X inactivation in healthy individuals and in different diseases. Acta Pædiatrica. 2006;95:24–9.
  14. Roberts RM, Katayama M, Magnuson SR, Falduto MT, Torres KEO. Transcript profiling of individual twin blastomeres derived by splitting two-cell stage murine embryos. Biol Reprod. 2011;84(3):487–94.
  15. Machin GA, Keith LG. An atlas of multiple pregnancy: biology and pathology. Taylor & Francis; 1999.
  16. Kulkarni AD, Jamieson DJ, Jones Jr HW, Kissin DM, Gallo MF, Macaluso M, et al. Fertility treatments and multiple births in the United States. N Engl J Med. 2013;369(23):2218–25.
  17. Hviid KVR, Malchau SS, Pinborg A, Nielsen HS. Determinants of monozygotic twinning in ART: a systematic review and a meta-analysis. Hum Reprod Update. 2018;24(4):468–83.
  18. Kanter JR, Boulet SL, Kawwass JF, Jamieson DJ, Kissin DM. Trends and correlates of monozygotic twinning after single embryo transfer. Obstet Gynecol. 2015;125(1):111.
  19. Knopman JM, Krey LC, Oh C, Lee J, McCaffrey C, Noyes N. What makes them split? Identifying risk factors that lead to monozygotic twins after in vitro fertilization. Fertil Steril. 2014;102(1):82–9.
  20. Mateizel I, Santos-Ribeiro S, Done E, Van Landuyt L, Van de Velde H, Tournaye H, et al. Do ARTs affect the incidence of monozygotic twinning? Hum Reprod. 2016;31(11):2435–41.
  21. Kiely JL, Kiely M. Epidemiological trends in multiple births in the United States, 1971–1998. Twin Res Hum Genet. 2001;4(3):131–3.
  22. Keith LG, Papiernik E. Multiple pregnancy: epidemiology, gestation, and perinatal outcome. CRC Press; 1995.
  23. Nylander PPS. The factors that influence twinning rates. Acta Genet medicae Gemellol twin Res. 1981;30(3):189–202.
  24. Dunson DB, Weinberg CR, Wilcox AJ. Modelling multiple ovulation, fertilization, and embryo loss in human fertility studies. Biostatistics. 2001;2(2):131–45.
  25. Girela E, Lorente JA, Alvarez JC, Rodrigo MD, Lorente M, Villanueva E. Indisputable double paternity in dizygous twins. Fertil Steril. 1997;67(6):1159–61.
  26. Segal NL. Forgotten twins. Twin Res Off J Int Soc Twin Stud. 2000;3(1):58.
  27. MacGillivray I, Corney G, Nylander PPS. Human multiple reproduction. WB Saunders; 1975.
  28. Eriksson AW, Fellman J. Seasonal variation of livebirths, stillbirths, extramarital births and twin maternities in Switzerland. Twin Res Hum Genet. 2000;3(4):189–201.
  29. Lewis CM, Healey SC, Martin NG. Genetic contribution to DZ twinning. Am J Med Genet. 1996;61(3):237–46.
  30. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nat Rev Genet. 2002;3(11):872.
  31. Busjahn A, Knoblauch H, Faulhaber H-D, Aydin A, Uhlmann R, Tuomilehto J, et al. A region on chromosome 3 is linked to dizygotic twinning. Nat Genet. 2000;26(4):398–400.
  32. St Clair JB, Golubovsky MD. Paternally derived twinning: a two century examination of records of one Scottish name. Twin Res Hum Genet. 2002;5(4):294–307.
  33. Bieber FR, Nance WE, Morton CC, Brown JA, Redwine FO, Jordan RL, et al. Genetic studies of an acardiac monster: evidence of polar body twinning in man. Science (80- ). 1981;213(4509):775–7.
  34. Tong S. Dizygotic to monozygotic twinning ratio at The Royal Women’s Hospital, Melbourn 1947–1997, compared with Australian national twinning incidence. Twin Res Hum Genet. 2000;3(1):12–6.
  35. Bensdorp AJ, Hukkelhoven CW, van der Veen F, Mol BWJ, Lambalk CB, van Wely M. Dizygotic twin pregnancies after medically assisted reproduction and after natural conception: maternal and perinatal outcomes. Fertil Steril. 2016;106(2):371–7.
  36. National Institute for Health and Care Excellence (NICE). Multiple pregnancy: antenatal care for twin and triplet pregnancies [Internet]. NICE, UK; 2011 [cited 2019 Jun 9]. Available from: https://www.nice.org.uk/guidance/cg129.
  37. Gabbett MT, Laporte J, Sekar R, Nandini A, McGrath P, Sapkota Y, et al. Molecular support for heterogonesis resulting in sesquizygotic twinning. N Engl J Med. 2019;380(9):842–9.
  38. Machin G. Non‐identical monozygotic twins, intermediate twin types, zygosity testing, and the non‐random nature of monozygotic twinning: A review. In: American Journal of Medical Genetics Part C: Seminars in Medical Genetics. Wiley Online Library; 2009. p. 110–27.